Skip to main content

Table 2 BAL inflammatory cells in the three in vivo models of lung inflammation

From: MMP/TIMP expression profiles in distinct lung disease models: implications for possible future therapies

Antigen Model

LPS Model

Elastase Model

 

Neutrophils

LMN

 

Eosinophils

LMN

 

Neutrophils

Eosinophils

2 hrs Veh

0.4 ± 0.3

173.8 ± 16.1

1 hr Veh

0.0 0.0

106.3 ± 20.1

2 hrs Veh

21.6 ± 5.9

1.1 ± 0.5

2 hrs OVA

11.7 ± 3.7

115.7 ± 18.8

1 hr LPS

6.1 ± 2.2

102.1 ± 10.7

2 hrs ELA

72.6 ± 15.8

0.0 ± 0.0

4 hrs Veh

2.8 ± 1.6

181.0 ± 16.0

2 hrs Veh

0.5 ± 0.3

155.7 ± 66.9

6 hrs Veh

80.3 ± 30.5

1.2 ± 0.4

4 hrs OVA

144.1 ± 60.1

99.0 ± 8.7

2 hrs LPS

31.9 ± 9.6

71.3 ± 8.9

6 hrs ELA

267 ± 86.7

1.9 ± 0.9

6 hrs Veh

1.5 ± 0.9

175.7 ± 21.3

4 hrs Veh

0.2 ± 0.2

80.7 ± 16.6

24 hrs Veh

46.8 ± 22.4

0.9 ± 0.4

6 hrs OVA

977.1 ± 300.9

150.7 ± 25.9

4 hrs LPS

95.1 ± 24.5

80.0 ± 18.5

24 hrs ELA

382.1 ± 77.4

4.3 ± 2.5

8 hrs Veh

0.2 ± 0.2

173.9 ± 12.3

6 hrs Veh

0.0 ± 0.0

151.8 ± 37.8

48 hrs Veh

8.6 ± 2.3

0.0 ± 0.0

8 hrs OVA

1324.5 ± 293.2

178.1 ± 23.0

6 hrs LPS

110.0 ± 28.3

112.1 ± 10.5

48 hrs ELA

529.4 ± 174.5

4.3 ± 4.3

12 hrs Veh

1.6 ± 0.6

176.4 ± 31.9

8 hrs Veh

0.0 ± 0.0

141.5 ± 31.5

72 hrs Veh

1.1 ± 0.6

0.5 ± 0.2

12 hrs OVA

998.7 ± 312.2

195.2 ± 27.0

8 hrs LPS

80.6 ± 11.2

139.3 ± 11.7

72 hrs ELA

83.2 ± 9.1

0.6 ± 0.6

24 hrs Veh

0.7 ± 0.4

171.2 ± 15.9

12 hrs Veh

0.1 ± 0.1

100.5 ± 13.9

96 hrs Veh

1.9 ± 1.4

0.3 ± 0.3

24 hrs OVA

317.4 ± 141.3

390.1 ± 85.9

12 hrs LPS

41.3 ± 6.5

213.3 ± 10.4

96 hrs ELA

18.1 ± 8.4

1.7 ± 0.9

   

24 hrs Veh

0.1 ± 0.1

98.8 ± 15.9

168 hrs Veh

17.2 ± 14.1

0.4 ± 0.4

   

24 hrs LPS

7.9 ± 2.0

75.5 ± 12.9

168 hrs ELA

0.6 ± 0.4

0.3 ± 0.3